Searching... Searching...
  • NVP -4.19%
  • Köp 3.15
  • Sälj 3.20
  • Senast 3.20
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Newsletters

November 2018

Interview with Mark Farmery, KL1333 towards European clinical trial, Vinnova funding for NV354, and much more

Read More

September 2018

NeuroVive recognizes Global Mitochondrial Disease Awareness Week

Read More

June 2018

Summer greetings from NeuroVive – agreement within the NVP015 program, Denise Goode – new member of the board

Read More

February 2018

Breakthrough brings hope of treatments for muscle diseases

Read More
  • Press Releases

    NeuroVive receives Vinnova funding to support development of NV354, a novel treatment for genetic mitochondrial disorders 15 November Lund, 15 November, 2018- NeuroVive Pharmaceutical AB(Nas... Read More